Publication | Closed Access

Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)

Hematological MalignancyNeoplastic DiseasesTransplantationMarrow TransplantationMedicineMyeloid MalignanciesHematologyStem Cell TransplantationCell BiologyFirst InductionOncologyCell TransplantationMyeloid Neoplasia